Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT04530812. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
ClinicalTrials.gov study NCT05992532. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05530421. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain
ClinicalTrials.gov study NCT03602755. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00594126. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
ClinicalTrials.gov study NCT05641324. IPD Sharing: NO. Countries: 5. Publications: 0.
Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05227144. IPD Sharing: NO. Countries: 2. Publications: 0.
Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03492138. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00516191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT02420860. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exercise Prescription for the Improvement of Quality of Life in Elderly Patients With Multiple Myeloma
ClinicalTrials.gov study NCT04100044. IPD Sharing: NO. Countries: 1. Publications: 0.
The Risk Stratification in Patients With Multiple Myeloma Based on Fluorescence Flow Cytometry Quantitative Determination of the Circulating Plasma Cells in the Peripheral Blood
ClinicalTrials.gov study NCT04242121. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Implication of Bone Marrow Perfusion Patterns Imaged by Dynamic MRI in Multiple Myeloma
ClinicalTrials.gov study NCT00166855. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02954796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT00438841. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
ClinicalTrials.gov study NCT03729804. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Assess Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05308225. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea
ClinicalTrials.gov study NCT02556905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Phase II Study in Elderly Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT04277845. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
ClinicalTrials.gov study NCT07106671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.